Expectations of biologically active compounds of the genus Magnolia in biomedicine

Journal of Applied Biomedicine

Volumn 4, Issue 4, 2006, Pages 171-178

  Patočka, Jiří ^a   Jakl, Jiří ^b   Strunecká, Anna ^c  

^a UNIVERSITY OF SOUTH BOHEMIA   (Czech Republic)

^b CZECH UNIVERSITY OF LIFE SCIENCES PRAGUE   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Herbal tranquillizer; Honokiol; Magnolia; Magnolol; Obovatol; Pharmacology

Indexed keywords

3,3' BIS ALLYLMAGNOLOL; ACETYLSALICYLIC ACID; ALCOHOL; ARACHIDONATE 5 LIPOXYGENASE; CALCITRIOL; HONOKIOL; MAGNOLIA EXTRACT; MAGNOLOL; N(G) NITROARGININE METHYL ESTER; OBOVATOL; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; PROSTAGLANDIN SYNTHASE; RETINOIC ACID; SAIBOKU TO; TETRAHYDROOBOVATOL;

ANTIARRHYTHMIC ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BRAIN ISCHEMIA; CANCER INHIBITION; DRUG ALCOHOL INTERACTION; DRUG STRUCTURE; EDEMA; HEART VENTRICLE ARRHYTHMIA; HERBAL MEDICINE; HUMAN; IC 50; LIVER TOXICITY; MAGNOLIA GRANDIFLORA; MAGNOLIA OBOVATA; MAGNOLIA OFFICINALIS; MAGNOLIACEAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OXIDATIVE STRESS; PROMYELOCYTIC LEUKEMIA; REPERFUSION INJURY; REVIEW; TRANQUILIZING ACTIVITY;

MAGNOLIA; MAGNOLIA OFFICINALIS; MAGNOLIACEAE;

EID: 33845657718     PISSN: 1214021X     EISSN: 12140287     Source Type: Journal    
DOI: 10.32725/jab.2006.019     Document Type: Review

References (59)

1. Ai J., Wang X., Nielsen M.: Honokiol and magnolol selectively interact with GABA(A) receptor subtypes in vitro. Pharmacology 63: 34-41, 2001.
2. Amblard F., Delinsky D., Arbiser J.L., Schinazi R.F.: Facile purification of honokiol and its antiviral and cytotoxic properties. J. Med. Chem. 49:3426-3427, 2006.
3. Azuma H., Garcia-Franco J.G., Rico-Gray V., Thien L.B.: Molecular phylogeny of the Magnoliaceae: the biogeography of tropical and temperate disjunctions. Am. J. Bot. 88: 2275-2285, 2001.
4. Bae E.A., Han M.J., Kim N.J., Kim D.H.: Anti-Helicobacter pylori activity of herbal medicines. Biol. Pharm. Bull. 21:990-992, 1998.
5. Bastidas Ramírez B.E., Navarro Ruíz N., Quezada Arellano J.D. et al.: Anticonvulsant effects of Magnolia grandiflora L. in the rat. J. Ethnopharmacol. 61:143-152, 1998.
6. Bateman J., Chapman R.D., Simpson D.: Possible toxicity of herbal remedies. Scott. Med. J. 43:7-15, 1998.
7. Cao J.X., Lai G.F., Wang Y.F. et al.: A new sesquiterpenoid from Magnolia delavayi. Chin. Chem. Lett. 15:791-793, 2004.
8. Chang B., Lee Y., Ku Y. et al.: Antimicrobial activity of magnolol and honokiol against periodontopathic microorganisms. Planta Med. 64:367-369, 1998.
9. Chang C.P., Hsu Y.C., Lin M.T.: Magnolol protects against cerebral ischemic injury of rat heat stroke. Clin. Exp. Pharmacol. Physiol. 30: 387-392, 2003.
10. Chen C., Xu X., Zhu Y. et al.: Determination of honokiol and magnolol in cortex Magnoliae Officinalis by capillary electrophoresis with electrochemical detection. J. Pharm. Biomed. Anal. 41:1479-1484, 2006.
11. Chen J.H, Wu C.C., Hsiao G., Yen M.H.: Magnolol induces apoptosis in vascular smooth muscle. Naunyn Schmiedebergs Arch. Pharmacol. 368: 127-133, 2003.
12. Clark A.M., El-Feraly F.S., Li W.S.: Antimicrobial activity of phenolic constituents of Magnolia grandiflora L. J. Pharm. Sci. 70:951-952, 1981.
13. Fong W. F., Tse A. K., Poon K.H., Wang C.: Magnolol and honokiol enhance HL-60 human leukemia cell differentiation induced by 1,25-dihydroxyvitamin D3 and retinoic acid. Int. J. Biochem. Cell. Biol. 37:427-441, 2005.
14. Fukuyama Y., Otoshi Y., Miyoshi K. et al.: Neurotrophic sesquiterpene-neolignans from Magnolia obovata - structure and neurotrophic activity. Tetrahedron 48:377-392, 1992.
15. Hegnauer R.: Chemotaxonomie der Pflanzen 9; Birkhaüser Verlag, Basel, Boston, Berlin 1990.
16. Ho K.Y., Tsai C.C., Chen C.P. et al.: Antimicrobial activity of honokiol and magnolol isolated from Magnolia officinalis. Phytother. Res. 15: 139-141, 2001.
17. Hong-Yen H., Chau-Shin H.: Commonly Used Chinese Herb Formulas with Illustrations. Oriental Healing Arts Institute, Long Beach, CA 1980.
18. Horigome H., Homma M., Hiran T. et al.: Magnolol from Magnolia officinalis inhibits 11 beta-hydroxysteroid dehydrogenase without increases of corticosterone and thymocyte apoptosis in mice. Planta Med. 67:33-37, 2001.
19. Hsu M.F., Lu M.C., Tsao L.T. et al.: Mechanisms of the influence of magnolol on eicosanoid metabolism in neutrophils. Biochem. Pharmacol. 67:831-840, 2004.
20. Hu S.: The Economic botany of Magnoliaceae. In: Liu Y., Fan H., Chen Z., et al. (eds). Proceedings of the Internetional Symposium on the Family Magnoliaceae, Science Press, Beijing 2000.
21. Hunt D.: Magnolias and their allies. The International Dendrology Society and the Magnolia Society, Milborne Port 1998.
22. Hwang E.I., Kwon B.M., Lee S.H. et al.: Obovatols, new chitin synthase 2 inhibitors of Saccharomyces cerevisiae from Magnolia obovata. J. Antimicrob. Chemother. 49:95-101, 2002.
23. Ikeda K., Nagase H.: Magnolol has the ability to induce apoptosis in tumor cells. Biol. Pharm. Bull. 25:1546-1549, 2002.
24. Ikeda K., Sakai Y., Nagase H.: Inhibitory effect of magnolol on tumour metastasis in mice. Phytother. Res. 17:933-937, 2003.
25. Ito K., Iida T., Ichino K. et al. Obovatol and obovatal, novel biphenyl ether lignans from the leaves of Magnolia obovata Thunb. Chem. Pharm. Bull. 30:3347-3353, 1982.
26. IUCN Red List of Threatened Species. IUCN 2004. http://www.iucnredlist.org/
27. Jinping S.: Jingning Magnolia officinalis development project, Jingning Science and Technology Development Department, Zhejiang, China 2000.
28. Kim S., Mark W.C., Parks C.R.: Phylogentic relationships in family Magnoliaceae inferred from ndhF sequences. Am. J. Bot. 88:717-728, 2001.
29. Kong Z.L., Tzeng S.C., Liu Y.C.: Cytotoxic neolignans: an SAR study. Bioorg. Med. Chem. Lett. 15:163-166, 2005.
30. Kwon B.M., Kim M.K., Lee S.H. et al.: Acyl-CoA cholesterol acyltransferase inhibitors from Magnolia obovata. Planta Med. 63: 550-551, 1997.
31. Kuribara H., Kishi E., Hattori N. et al.: Application of the elevated plus-maze test in mice for evaluation of the content of honokiol in water extracts of magnolia. Phytother. Res. 13:593-596, 1999.
32. Lee J., Jung E., Park J. et al.: Anti-inflammatory effect of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF-kappa B activation signaling. Planta Med. 71:338-343, 2005.
33. Lee M.M., Huang H.M., Hsieh M.T. et al.: Anti-inflammatory and neuroprotective effects of magnolol in chemical hypoxia in rat cultured cortical cells in hypoglycemic media. Chin. J. Physiol. 43:61-67, 2000.
34. Li C.Y., Wang Y., Hu M.K.: Allylmagnolol, a novel magnolol derivative as potent antioxidant. Bioorg. Med. Chem. 11:3665-3671, 2003.
35. Li J., Tanaka M., Kurasawa K. et al.: Lignan and neolignan derivatives from Magnolia denudata. Chem. Pharm. Bull. (Tokyo) 53: 235-237, 2005.
36. Lin S.Y., Chang Y.T., Liu J.D. et al.: Molecular mechanisms of apoptosis induced by magnolol in colon and liver cancer cells. Mol. Carcinog. 32:7-83, 2001.
37. Lin S.Y., Liu J.D., Chang H.C. et al.: Magnolol suppresses proliferation of cultured human colon and liver cancer cells by inhibiting DNA synthesis and activating apoptosis. J. Cell. Biochem. 84:532-544, 2002.
38. Lin Y.R., Chen H.H., Ko C.H., Chan M.H.: Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage. Eur. J. Pharmacol. 537: 64-69, 2006.
39. Liou K.T., Shen Y.C., Chen C.F. et al.: The anti-inflammatory effect of honokiol on neutrophils: mechanisms in the inhibition of reactive oxygen species production. Eur. J. Pharmacol. 475:19-27, 2003.
40. Liu L., Wu X., Fan X., Hu Z.: Separation and determination of honokiol and magnolol in herbal medicines by flow injection-capillary electrophoresis. Anal. Bioanal. Chem. 384: 1533-1539, 2006.
41. Luo X.D., Wu S.H., Ma Y.B. et al.: Sesquiterpenoids from Magnolia grandiflora. Planta Med. 67:354-357, 2001.
42. Maruyama Y., Kuribara H., Morita M. et al.: Identification of magnolol and honokiol as anxiolytic agents in extracts of Saiboku-to, an oriental herbal medicine. J. Nat. Prod. 61:135-138, 1998.
43. Matsuda H., Kageura T., Oda M. et al.: Effects of constituents from the bark of Magnolia obovata on nitric oxide production in lipopolysaccharide-activated macrophages. Chem. Pharm. Bull. (Tokyo) 49:716-720, 2001.
44. Matsui N., Nakashima H., Ushio Y. et al.: Neurotrophic effect of magnolol in the hippocampal CA1 region ofsenescence-accelerated mice (SAMP1). Biol. Pharm. Bull. 28:1762-1765, 2005.
45. Park E.J., Zhao Y.Z., Na M. et al.: Protective effects of honokiol and magnolol on tertiary butyl hydroperoxide- or D-galactosamine-induced toxicity in rat primary hepatocytes. Planta Med. 69:33-37, 2003.
46. Park J., Lee J., Jung E. et al.: In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp. Eur. J. Pharmacol. 496:189-195, 2004.
47. Patočka J., Strunecká A., Jakl J.: Magnolia can be not only beatiful, but also helpful. Psychiatrie 6: 247-251, 2002.
48. Pharmacopoeia of the PRC (English edition). People's Medical Publishing House, Beijing 1988.
49. Shih H.C., Wei Y.H., Lee C.H.: Magnolol alters the course of endotoxin tolerance and provides early protection against endotoxin challenge following sublethal hemorrhage in rats. Shock 22:358-363, 2004.
50. 3H] muscimol binding sites three-fold in rat forebrain membranes in vitro using a filtration assay, by allosterically increasing the affinities of low-affinity sites. Neurochem. Res. 24: 1593-1602, 1999.
51. Tachikawa E,, Takahashi M,, Kashimoto T.: Effects of extract and ingredients isolated from Magnolia obovata Thunberg on catecholamine secretion from bovine adrenal chromaffin cells. Biochem. Pharmacol. 60:433-440, 2000.
52. Tsai S.K., Huang S.S., Hong C.Y.: Myocardial protective effect of honokiol: an active component in Magnolia officinalis. Planta Med. 62:503-506, 1996.
53. Tsai S.K., Huang C.H., Huang S.S. et al.: Antiarrhythmic effect of magnolol and honokiol during acute phase of coronary occlusion in anesthetized rats: influence of LNAME and aspirin. Pharmacology 59:227-233, 1999.
54. Wang J.P., Ho T.F., Chang L.C., Chen C.C.: Anti-inflammatory effect of magnolol, isolated from Magnolia officinalis, on A23187-induced pleurisy in mice. J. Pharm. Pharmacol. 47: 857-860, 1995.
55. Wang J.P., Hsu M.F., Raung S.L. et al.: Anti-inflammatory and analgesic effects of magnolol. Naunyn Schmiedebergs Arch. Pharmacol. 346:707-712, 1992.
56. Watanabe K., Watanabe H., Goto Y. et al.: Pharmacological properties of magnolol and honokiol extracted from Magnolia officinalis - central depressant effects. Planta Med. 49: 103-108, 1983.
57. Yang M.H., Blunden G., Patel A.V. et al.: Coumarins and sesquiterpene lactones from Magnolia grandiflora leaves. Planta Med. 60:390-390, 1994.
58. Yang S.E., Hsieh M.T., Tsai T.H., Hsu S.L.: Effector mechanism of magnolol-induced apoptosis in human lung squamous carcinoma CH27 cells. Br. J. Pharmacol. 138:193-201, 2003.
59. Zhong W.B., Wang C.Y., Ho K.J. et al.: Magnolol induces apoptosis in human leukemia cells via cytochrome C release and caspase activation. Anticancer Drugs 14:211-217, 2003.